| 000 | 01651 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514004749.0 | ||
| 264 | 0 | _c20011004 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a1051-0443 | ||
| 024 | 7 |
_a10.1016/s1051-0443(07)61575-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPonec, D | |
| 245 | 0 | 0 |
_aRecombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. _h[electronic resource] |
| 260 |
_bJournal of vascular and interventional radiology : JVIR _cAug 2001 |
||
| 300 |
_a951-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCatheterization, Central Venous |
| 650 | 0 | 4 | _aCatheters, Indwelling |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEquipment Failure |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aIrwin, D | |
| 700 | 1 | _aHaire, W D | |
| 700 | 1 | _aHill, P A | |
| 700 | 1 | _aLi, X | |
| 700 | 1 | _aMcCluskey, E R | |
| 773 | 0 |
_tJournal of vascular and interventional radiology : JVIR _gvol. 12 _gno. 8 _gp. 951-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1051-0443(07)61575-9 _zAvailable from publisher's website |
| 999 |
_c11414537 _d11414537 |
||